Thomas Reilly

2021

In 2021, Thomas Reilly earned a total compensation of $810K as Chief Financial Officer at Cara Therapeutics, a 49% decrease compared to previous year.

Compensation breakdown

Bonus$82,400
Non-Equity Incentive Plan$164,800
Salary$412,000
Stock Awards$139,067
Other$11,736
Total$810,003

Reilly received $412K in salary, accounting for 51% of the total pay in 2021.

Reilly also received $82.4K in bonus, $164.8K in non-equity incentive plan, $139.1K in stock awards and $11.7K in other compensation.

Rankings

In 2021, Thomas Reilly's compensation ranked 9,449th out of 12,415 executives tracked by ExecPay. In other words, Reilly earned more than 23.9% of executives.

ClassificationRankingPercentile
All
9,449
out of 12,415
24th
Division
Manufacturing
4,190
out of 5,505
24th
Major group
Chemicals And Allied Products
1,854
out of 2,375
22nd
Industry group
Drugs
1,646
out of 2,096
22nd
Industry
Pharmaceutical Preparations
1,223
out of 1,546
21st

Pay ratio

Thomas Reilly's Pay$810,003
Median Employee's Pay$192,240
Pay Ratio

4

to 1

In 2021, the annual total compensation of Thomas Reilly was $810,003.

The annual total compensation of the median employee at Cara Therapeutics was $192,240.

The ratio of Thomas Reilly's pay to the pay of median employee was therefore 4 to one.

Source: SEC filing on April 22, 2022.

Reilly's colleagues

We found five more compensation records of executives who worked with Thomas Reilly at Cara Therapeutics in 2021.

2021

Derek Chalmers

Cara Therapeutics

Chief Executive Officer

2021

Christopher Posner

Cara Therapeutics

Chief Executive Officer

2021

Frédérique Menzaghi

Cara Therapeutics

Chief Scientific Officer

2021

Joana Goncalves

Cara Therapeutics

Chief Medical Officer

2021

Scott Terrillion

Cara Therapeutics

General Counsel

News

You may also like